Compass Therapeutics Inc. (CMPX): Price and Financial Metrics
CMPX Price/Volume Stats
Current price | $3.38 | 52-week high | $4.08 |
Prev. close | $3.45 | 52-week low | $0.76 |
Day low | $3.37 | Volume | 608,600 |
Day high | $3.66 | Avg. volume | 2,260,640 |
50-day MA | $2.25 | Dividend yield | N/A |
200-day MA | $1.63 | Market Cap | 465.05M |
CMPX Stock Price Chart Interactive Chart >
Compass Therapeutics Inc. (CMPX) Company Bio
Compass Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of proprietary antibody therapeutics. immuno-oncology product candidates include a clinical-stage monoclonal antibody targeting solid tumors, a novel bispecific targeting PD-1 and PD-L1, and a portfolio of bispecific and monoclonal antibodies at various stages of pre-clinical development. The company was founded by Thomas J. Schuetz on March 20, 2018 and is headquartered in Boston, MA.
CMPX Price Returns
1-mo | 30.00% |
3-mo | 150.37% |
6-mo | 188.89% |
1-year | 78.84% |
3-year | 34.13% |
5-year | N/A |
YTD | 133.10% |
2024 | -7.05% |
2023 | -68.99% |
2022 | 58.68% |
2021 | N/A |
2020 | N/A |
Loading social stream, please wait...